119
A. E. Williamson et al.
Letter
Synlett
this, we prepared the linear precursor 9 bearing a tethered
oxygen nucleophile. Although the dearomatization condi-
tions reported above provided the desired cyclohexadien-
one 10 in moderate yields, an adaptation of the conditions
reported by Ciufolini and Liang was found to be more effec-
tive,15 affording the dearomatized spirocyclic intermediate
10 in 96% isolated yield (Scheme 3). Subsequent enantiose-
lective desymmetrization of the purified intermediate 10
by using 20 mol% of amine catalyst 5b in dichloromethane
at –40 °C provided the structurally complex tricycle 11 in
49% yield, 98% ee, and 7:1 dr.
(2) For recent reviews of oxidative dearomatization, see:
(a) Ciufolini, M. A.; Braun, N. A.; Canesi, S.; Ousmer, M.; Chang,
J.; Chai, D. Synthesis 2007, 3759. (b) Zhuo, C.-X.; Zhang, W.; You,
S.-L. Angew. Chem. Int. Ed. 2012, 51, 12662.
(3) For recent reviews on oxidative dearomatization in natural
product synthesis, see: (a) Pouységu, L.; Deffieux, D.; Quideau,
S. Tetrahedron 2010, 66, 2235. (b) Roche, S. P.; Porco, J. A. Jr.
Angew. Chem. Int. Ed. 2011, 50, 4068.
(4) (a) Imbos, R.; Minnaard, A. J.; Feringa, B. L. J. Am. Chem. Soc.
2002, 124, 184. (b) Hayashi, Y.; Gotoh, H.; Tamura, T.;
Yamaguchi, H.; Masui, R.; Shoji, M. J. Am. Chem. Soc. 2005, 127,
16028. (c) Liu, Q.; Rovis, T. J. Am. Chem. Soc. 2006, 128, 2552.
(d) Vo, N. T.; Pace, R. D. M.; O’Hara, F.; Gaunt, M. J. J. Am. Chem.
Soc. 2008, 130, 404. (e) Gu, Q.; Rong, Z.-Q.; Zheng, C.; You, S.-L.
J. Am. Chem. Soc. 2010, 132, 4056. (f) Leon, R.; Jawalekar, A.;
Redert, T.; Gaunt, M. J. Chem. Sci. 2011, 2, 1487. (g) Wu, Q.-F.;
Liu, W.-B.; Zhuo, C.-X.; Rong, Z.-Q.; Ye, K.-Y.; You, S.-L. Angew.
Chem. Int. Ed. 2011, 50, 4455. (h) Rubush, D. M.; Morges, M. A.;
Rose, B. J.; Thamm, D. H.; Rovis, T. J. Am. Chem. Soc. 2012, 134,
13554. (i) Corbett, M. T.; Johnson, J. S. Chem. Sci. 2013, 4, 2828.
(j) Xu, R.-Q.; Gu, Q.; Wu, W.-T.; Zhao, Z.-A.; You, S.-L. J. Am.
Chem. Soc. 2014, 136, 15469.
(5) For reviews of the Erythrina alkaloid family, see: (a) Dyke, S. F.;
Quessy, S. N. In The Alkaloids: Chemistry and Physiology; Vol. 18;
Manske, R. F. H.; Rodrigo, R. G. A., Eds.; Academic Press: New
York, 1981, 1. (b) Tsuda, Y.; Sano, T. In The Alkaloids: Chemistry
and Pharmacology; Vol. 48; Cordell, G. A., Ed.; Academic Press:
San Diego, 1996, 249. (c) Parsons, A. F.; Palframan, M. J. In The
Alkaloids: Chemistry and Biology; Vol. 68; Cordell, G. A., Ed.;
Academic Press: San Diego, 2010, 39.
(6) For biological activities of the Erythrina alkaloids, see:
(a) Lehman, A. J. J. Pharmacol. Exp. Ther. 1937, 60, 69. (b) Folkers,
K.; Unna, K. J. Am. Pharm. Assoc. 1938, 27, 693. (c) Folkers, K.;
Unna, K. J. Am. Pharm. Assoc. 1939, 28, 1019. (d) Craig, L. E. In
The Alkaloids: Chemistry and Physiology; Vol. 5; Manske, R. F. H.,
Ed.; Academic Press: New York, 1955, 265.
(7) (a) Marigo, M.; Wabnitz, T. C.; Fielenbach, D.; Jørgensen, K. A.
Angew. Chem. Int. Ed. 2005, 44, 794. (b) Hayashi, Y.; Gotoh, H.;
Hayashi, T.; Shoji, M. Angew. Chem. Int. Ed. 2005, 44, 4212.
(8) Initially, the syn-diastereomer 3 is formed by the desymmetriz-
ing Michael addition; however, this isomer is configurationally
unstable and epimerizes to the more stable anti-diastereomer
4a upon standing.
OH
O
O
OH
PhI(OTFA)2 (1.2 equiv)
TFA (1.6 equiv)
96% yield
O
O
N
N
O
MeCN (0.008 M)
0 °C, 1 h
O
9
10
H
H
20 mol% 5b
CH2Cl2 (0.056 M)
–40 °C, 2 d
O
O
H
49% yield, 98% ee
7:1 dr
O
N
O
H
H
11
Scheme 3 Application of CED to a complex non-natural scaffold
In summary, we have demonstrated that our CED proto-
col provides a versatile method for rapidly generating mo-
lecular complexity from simple phenol-based precursors.
The generality of this approach has been demonstrated
through the enantioselective assembly of a number of com-
plex natural product scaffolds, including those of the Eryth-
rina alkaloids and (–)-morphine. Further investigations into
the applications of this protocol in natural product synthe-
sis are ongoing in our laboratory.
Acknowledgements
We are grateful to the EPSRC (T.N.) and Pfizer Global Research and De-
velopment (R.D.M.P.) for studentships, and to the Marie Curie Foun-
dation for fellowships (A.E.A and J.D.C). Mass spectrometry data were
acquired at the EPSRC UK National Mass Spectrometry Facility at
Swansea University.
(9) When this is performed as a one-pot procedure in 2,2,2-trifluo-
roethanol, tetracycle 4a is obtained in 50% yield and 82% ee.
(10) Dearomatization of Aromatic Phenols with Intramolecular
Carbon Nucleophiles: General Procedure
The appropriate phenol (1.0 equiv) was dissolved in F3CCH2OH
(0.034 M), and the solution was cooled to 0 °C or –40 °C.
PhI(OAc)2 or PhI(O2CCF3)2 (1.1 equiv) was added, and the
mixture was stirred at 0 °C or at –40 °C for 30 min. The reaction
was quenched by addition of H2O at 0 °C or at –40 °C, and the
mixture was extracted with CH2Cl2 (×2). The combined organic
layers were washed with brine, dried (MgSO4), filtered, and
concentrated in vacuo to give a crude product that was either
used in the crude state or purified by flash chromatography to
give the desired cyclohexadienone.
Asymmetric Organocatalytic Conjugate Addition: General
Procedure
The crude cyclohexadienone was dissolved in anhydrous MeCN
(0.056 M), and the mixture was cooled to –40 °C. The appropri-
ate organocatalyst (0.1 equiv) and BzOH (0–0.1 equiv) were
added, and the mixture was stirred at –40 °C for the appropriate
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
References and Notes
(1) (a) Walji, A. M.; MacMillan, D. W. C. Synlett 2007, 1477.
(b) Wender, P. A.; Miller, B. L. Nature 2009, 460, 197.
(c) Newhouse, T.; Baran, P. S.; Hoffmann, R. W. Chem. Soc. Rev.
2009, 38, 3010.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, 116–120